|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| C07K 16/241 | (2013.01) | ||
| C07K2317/41 | (2013.01) | ||
| C07K2317/524 | (2013.01) | ||
| C07K2317/526 | (2013.01) | ||
| C07K2317/72 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/734 | (2013.01) | ||
| C07K2317/74 | (2013.01) | ||
| C07K2317/77 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/76 | (2013.01) |
| (11) | Patento numeris | 3456737 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17191988.9 |
| Europos patento paraiškos padavimo data | 2017-09-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (72) |
FURRER, Esther , CH
|
| (73) |
TILLOTTS PHARMA AG ,
Baslerstrasse 15, 4310 Rheinfelden,
CH
|
| (54) | ANTIBODY VARIANTS |
| ANTIBODY VARIANTS |